Trial Information

Summary: End-stage Renal Disease Hemodialysis

The purpose of this study is to test a new liquid drug (during the dialysis procedure) containing iron that may help maintain your iron storage ability for people who are on chronic hemodialysis for end-stage renal disease.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

  • Be at least 18 years old undergoing chronic hemodialysis for end-stage renal disease three times a week

You will not qualify if you:

  • Are pregnant or breast-feeding
  • Have HIV
  • Have active infections
  • Have participated in a clinical drug or device trial within the last 30 days

Contact:

Susan Mathew, Research Coordinator
Biomedical Research Alliance of New York
North Shore University Hospital
100 Community Drive - 2nd Floor
Great Neck, NY 11021
Telephone: 516-465-8200
Email:

Profile Page: Biomedical Research Alliance of New York, Great Neck, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:45:08 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA